nausea

Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer

...(72%/71%),dysphagia (65%/63%), asthenia (56%/49%), nausea (49%/37%),constipation (35%/30%) and vomiting (29%...%), asthenia/malaise(73%/48%), diarrhea (72%/25%), nausea (55%/29%), abdominal pain(45%/26%), vomiting (41%/25%), fever (34%/27%), constipation(30%/26%), and ...

TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials

...placebo arm were rash (20 percent vs. 10 percent), nausea (14percent vs. 12 percent), diarrhea (12 percent v.... 9 percent), diarrhea (18 percentvs. 20 percent), nausea (14 percent vs. 10 percent), injection sitereaction (13 percent vs. 15 percent), headache (9 percent...

New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV

... regardless of severity werediarrhea (32 percent), nausea (18 percent), nasopharyngitis (12percent), headach...eported adverse events were diarrhea (42 percent), nausea (21percent) and nasopharyngitis (11 percent). Grade 2-4 diarrheaoccurred in 8 percent of patients ta...

Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine

... 49% (Grade 3/4: 8%); alopecia 48% (Grade3/4: 0%); nausea 42% (Grade 3/4: 2%); stomatitis/mucositis 29%(Grade 3/4: 7%); vomiting 29% (Grade 3/4: 1%); diarrhea 22% (Grade3/4: 1%); and musculoskeletal pain 20% (Grade 3/4: 3%).Treatment-related hematological adverse events greater than orequal to 20% included:...

Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial

...4.6%), headache (cethromycin 3.1%,Biaxin(R) 6.5%), nausea (cethromycin 2.7%, Biaxin(R) 3.8%),vomiting (cethromycin 2.7%, Biaxin(R) 1.5%), abdominal pain(cethromycin 1.5%, Biaxin(R) 3.1%) and taste disturbance(cethromycin 11.1%, Biaxin(R) 6.2%). No drug-related seriousadverse events were observed in any stud...

Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival

...rted adverse eventswere asthenic conditions (64%), nausea (55%) in single-agentVELCADE, diarrhea (52%), constipation (41%), peripheral neuropathy(39%), thrombocytopenia (36%), appetite decrease, including reportsof anorexia (36%), pyrexia (34%), vomiting (33%) and anemia (29%).Twenty percent of patients rep...

Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma

...rted adverse eventswere asthenic conditions (64%), nausea (55%) in single-agentVELCADE, diarrhea (52%), constipation (41%), peripheral neuropathy(39%), thrombocytopenia (36%), appetite decrease, including reportsof anorexia (36%), pyrexia (34%), vomiting (33%) and anemia (29%).Twenty percent of patients rep...

Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients

...rted adverse eventswere asthenic conditions (64%), nausea (55%) in single-agentVELCADE, diarrhea (52%), constipation (41%), peripheral neuropathy(39%), thrombocytopenia (36%), appetite decrease, including reportsof anorexia (36%), pyrexia (34%), vomiting (33%) and anemia (29%).Twenty percent of patients rep...

An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes

...dominal pain (JANUVIA 100 mg, 2.3%; placebo,2.1%), nausea (1.4%, 0.6%), and diarrhea (3.0%, 2.3%). No clinically meaningful changes in vital signs or in ECG(including in QTc interval) were observed in patients treated withJANUVIA. Laboratory Tests The incidence of laboratory adverse reactions in pa...

First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes

...e, 2/6 onplacebo+metformin, 1/2 on placebo alone), nausea (n=5; 4/19 ondapagliflozin+metformin, 1/6 on placebo+metformin), and diarrhea(n=4; 3/19 on dapagliflozin+metformin, 1/6 onplacebo+metformin). Preclinical Data Also Presented at 2007 American DiabetesAssociation Annual Meeting In a second presentati...

Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog Liraglutide, Brings Patients to A1c Target

... diarrhea (9%versus 4%), gastritis (7% vs. 0%) and nausea (7% versus 2%). Nosubject had a treatment-related increase in liraglutideantibodies. About liraglutide Currently in phase 3 clinical trials, liraglutide is a humananalog of the naturally occurring hormone, Glucagon-Like Peptide-1(GLP-1), which is r...

Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes

...dominal pain (JANUVIA 100 mg, 2.3%; placebo,2.1%), nausea (1.4%, 0.6%), and diarrhea (3.0%, 2.3%). No clinically meaningful changes in vital signs or in ECG(including in QTc interval) were observed in patients treated withJANUVIA. Laboratory Tests The incidence of laboratory adverse reactions in pa...

Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study

...y reported adverse event in theliraglutide arm was nausea at an absolute level of between 10 and15%. As expected, the combination of a GLP-1 analogue with asulfonylurea leads to some of the patients experiencinghypoglycaemia. The overall hypoglycaemia event rate in theliraglutide and insulin glargine groups...

Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial

...4.6%),headache (cethromycin 3.1%, Biaxin(R) 6.5%), nausea (cethromycin2.7%, Biaxin(R) 3.8%), vomiting (cethromycin 2.7%, Biaxin(R) 1.5%),abdominal pain (cethromycin 1.5%, Biaxin(R) 3.1%) and tastedisturbance (cethromycin 11.1%, Biaxin(R) 6.2%). No drug-relatedserious adverse events were observed in any stud...

Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop

...rted adverse eventswere asthenic conditions (64%), nausea (55%) in single-agentVELCADE, diarrhea (52%), constipation (41%), peripheral neuropathy(39%), thrombocytopenia (36%), appetite decrease, including reportsof anorexia (36%), pyrexia (34%), vomiting (33%) and anemia (29%).Twenty percent of patients rep...

Salix Pharmaceuticals Announces Positive Top Line Results of Balsalazide Tablets Registration Study

... headache(8%); abdominal pain (6%); diarrhea (5%); nausea (5%); vomiting(4%); respiratory infection (4%); and arthralgia (4%). Withdrawalfrom therapy due to adverse events was comparable to placebo. Salix also markets XIFAXAN(R) (rifaximin) tablets 200 mg ,OSMOPREP(TM) Tablets (sodium phosphate monobasic m...

Enbrel Safety Data for up to Eight Years in Patients with Juvenile Rheumatoid Arthritis Being Presented at EULAR

...fection, headache, abdominal pain, vomiting, and nausea occurred more frequently than in adults -- The kinds of infections reported were generally mild and similar to those usually seen in children -- Other serious adverse reactions were reported rarely, including serious infection (2%...

Critical Therapeutics Announces the Publication of Data for ZyfloCR (Zileuton) Extended-Release Tablets in the Journal of Asthma

...d with the use of ZYFLO CR andZYFLO are sinusitis, nausea and pharyngolaryngeal pain andabdominal pain, upset stomach and nausea, respectively. For full prescribing information for ZYFLO CR, please visitwww.zyflocr.com or call the Company's toll free telephone number1-866-835-8216 to request medical inform...

Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine

...reupper respiratory tract infection (37 patients), nausea (36patients), and dizziness (31 patients). Most ad...ely reduce thedebilitating symptoms, such as pain, nausea and vomiting, nor themigraine's duration. For more information about MM, visit<a target="_blank"...

NuPathe Reports Positive Phase One Results for NP101 Transdermal Therapy for Acute Migraine

...s who experience gastrointestinaldisorders such as nausea and vomiting during their migraineattack." According to Jane Hollingsworth, CEO of NuPathe, "Patients needbetter options for treatment of acute migraine attacks. Triptans,which are considered the gold standard in treatment today, areproven to be eff...

Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits

...morphine * Statistically significant reduction in nausea in the femalepatient population compared to morphi...phine but inducedsignificantly less post-operative nausea and vomiting (PONV). Sedation Analysis of the sedation data from the M6G022 trial showedstatistica...

International Movement Disorder Specialists Receive New Information About the Use of Once-Daily Azilect in the Treatment of Parkinson's Disease

... thinking, seizures, chest pain, unexplained nausea or vomiting, or signs or symptoms of a stroke. You or your caregiver should seek immediate medical attention if these symptoms or other unusual symptoms occur. -- In order to prevent a possibly dangerous increase in blood pressure, ...

Merck's Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study

...drelief of migraine-associated symptoms, including nausea andsensitivity to light and sound, and improved functional disabilitytwo hours post dose, as well as reduced patients' need for rescuemedication. However, the study was not powered to evaluate astatistical response to these measures. In the study, t...

Extensive Clinical Data on Erbitux Presented at the 2007 ASCO Annual Meeting

...(72%/71%),dysphagia (65%/63%), asthenia (56%/49%), nausea (49%/37%),constipation (35%/30%) and vomiting (29%...%), asthenia/malaise(73%/48%), diarrhea (72%/25%), nausea (55%/29%), abdominal pain(45%/26%), vomiting (41%/25%), fever (34%/27%), constipation(30%/26%), and ...

Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of Erbitux for Colorectal and Head and Neck Cancer Patients

...e 15symptom scales, including pain (p<0.0001), nausea (p<0.0001)and global health status (p=0.047). “The first set of data from the EPIC trial demonstratedthat progression-free survival and tumor shrinkage increasedsignificantly when Erbitux was administered to this patientpopulation. It is t...

MGI Pharma Summarizes Data Presented at the 2007 American Society of Clinical Oncology (ASCO) Annual Meeting

...nthe enhanced protection from chemotherapy-induced nausea andvomiting (CINV) observed with Aloxi in clinical...r rescue medication), no emesis, and nosignificant nausea (Visual Analogue Score (VAS; 0-100) less than25) on Day 1, during the delayed period of Days 2-5, an...

Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors

...mmonly occurring adversereactions by SC route were nausea (70.5%), anemia (69.5%),thrombocytopenia (65.5%), ... the mostcommonly occurring adverse reactions were nausea (70.5%), anemia(69.5%), thrombocytopenia (65.5%), vomiting (54.1%), pyrexia(51.8%), leukopenia (48.2...

MGI Pharma, Inc. Summarizes Data Presented at the 2007 American Society of Clinical Oncology (ASCO) Annual Meeting

...n the enhanced protection fromchemotherapy-induced nausea and vomiting (CINV) observed with Aloxiin clinical...r rescue medication), no emesis, and nosignificant nausea (Visual Analogue Score (VAS; 0-100) less than25) on Day 1, during the delayed period of Days 2-5, an...

New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by Paclitaxel

...t for the prevention of chemotherapy-induced nausea and vomiting associated with carboplatin-containing chemotherapy regimen in patients with ovarian cancer, primary peritoneal or fallopian tube carcinoma (stage I-IV) or papillary serous cancer of the uterus -- Craig Reynolds, M.D...

New Data on Market-Leading Velcade (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma

...rted adverse eventswere asthenic conditions (64%), nausea (55%) in single-agentVELCADE, diarrhea (52%), constipation (41%), peripheral neuropathy(39%), thrombocytopenia (36%), appetite decrease, including reportsof anorexia (36%), pyrexia (34%), vomiting (33%) and anemia (29%).Twenty percent of patients rep...

Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)

...in the ONTAK-treated patientsincluded fever (56%), nausea (54%), fatigue (45%), rigors (45%),headache (27%), vomiting (25%), peripheral edema (23%), rash (22%),diarrhea (22%), myalgia (19%), cough (19%), asthenia (18%),pruritus (17%), back pain (17%), anorexia (15%), arthralgia (14%)and upper respiratory tr...

Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting

...grade 3 or 4gastrointestinal toxicities, including nausea (1.3%), vomiting(1.6%), diarrhea (2.1%) and constipation (2.1%). Additionally, 5%or less of patients in the satraplatin arm experienced grade 3 or 4fatigue (1.7%), grade 3 or 4 infections (4.0%) andpulmonary/respiratory grade 3 or 4 toxicities (3.0%)...

Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting

...grade 3 or 4gastrointestinal toxicities, including nausea (1.3%), vomiting(1.6%), diarrhea (2.1%) and constipation (2.1%). Additionally, 5%or less of patients in the satraplatin arm experienced grade 3 or 4fatigue (1.7%), grade 3 or 4 infections (4.0%) andpulmonary/respiratory grade 3 or 4 toxicities (3.0%)...

AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results for Anti-Cancer Compound Perifosine at ASCO Meeting

...or fatigue. Thepercentage of patients with grade 0 nausea (N), vomiting (V),diarrhea (D) and fatigue (F) for lower dose perifosine (76patients) was 46, 49, 38 and 55% respectively compared to 26, 32,20 and 58 percent for higher dose perifosine (69 patients). Theproportion of patients with grade 2+ N, V, D a...

Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer Treatment

...penia (2%); fatigue(17%); thrombsis/embolism (6%); nausea (12%); vomiting (11%);dyspnea (11%); and chest pai...ades) were fatigue (80%);thrombosis/embolism (7%); nausea (84%); vomiting (58%);constipation (44%); anorexia (35%); stomatitis/pharyngitis (28%);diarrhea (26%...

Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents

... somnolence (27 percent), fatigue (9.4 percent)and nausea (5.1 percent). Small to modest changes in bloodpressure, pulse rate, and ECG were observed with GXR but were notclinically meaningful. Long-Term ADHD Symptom Improvement with GXR Trial 303 was a long-term, open-label, safety follow-up study of240 p...

Investigational Study Evaluates the Effectiveness of Aripiprazole in Adolescents With Schizophrenia

...renia or bipolar mania the following was reported: nausea (9% vs 3%). Treatment-emergent adverse even..., anxiety (20% vs 17%), insomnia (19% vs 14%), nausea (16% vs 12%), vomiting (12% vs 6%), dizziness (11% vs 8%), constipation (11% vs 7%), dyspepsia (...

Study Suggests Strattera Improved ADHD Symptoms in Patients With Comorbid Alcohol Abuse

...cal studies wereupset stomach, decreased appetite, nausea and vomiting, dizziness,tiredness and mood swings. In adults, the most common side effectswere constipation, dry mouth, nausea, decreased appetite,dizziness, problems sleeping, sexual side effects, problemsurinating and menstrual cramps. For Medicat...

Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls

... trial were decreasedappetite, headache, insomnia, nausea and vomiting. Boys in theDAYTRANA group had a higher incidence of vomiting (9 boys vs. 1girl), tic (7 vs. 0), upper abdominal pain (6 vs. 1), irritability(7 vs. 0) and affect lability (6 vs. 0). The study was supported by funding from Shire. About ...

Separate Sets of Research Show Treatment Improved Quality of Life in as Early as Three Weeks; Patient Adherence to Medication is Multifactorial

...), eructation (16% vs. 15%), pain (14% vs. 8%) and nausea (13%vs. 15%); for the maintenance of remission of UC, the most frequentadverse events were headache (50% vs. 50%), rhinitis (42% vs. 36%),diarrhea (35% vs. 50%), abdominal pain (32% vs. 44%) and flatulence(24% vs. 30%). Asacol is contraindicated in ...

New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder

...ost frequent treatment-emergentadverse events were nausea and headache. Nausea generally wastransient, usual...te/desvenlafaxine succinate group. Theincidence of nausea was highest for the placebo/desvenlafaxinesuccinate group during the first week of treatment and dec...

Additional Efficacy Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at Annual Meeting of American Urological Association

...grade 3 or 4 gastrointestinaltoxicities, including nausea (1.3%), vomiting (1.6%), diarrhea(2.1%) and constipation (2.1%). Five percent or less of patients inthe satraplatin arm experienced grade 3 or 4 fatigue, grade 3 or 4infections and pulmonary/respiratory grade 3 or 4 toxicities. About Satraplatin Sa...

Six-Week Investigational Study In Adults With Major Depressive Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole Therapy With Antidepressants

...renia or bipolar mania the following was reported: nausea (9% vs 3%). Treatment-emergent adverse ev...anxiety (20% vs 17%), insomnia (19% vs 14%), nausea (16% vs 12%), vomiting (12% vs 6%), dizziness (11% vs 8%), constipation (11% vs 7%), dyspepsia...

FDA approves IND on Lead Product M6G

...phine but inducedsignificantly less post-operative nausea and vomiting (PONV). Theopening trial under this I...n the unpleasant sideeffects experienced, of which nausea and vomiting are the mostcommon. PONV is rated among patients as one of the most distressingafter-ef...

Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage 2 Patients Compared With Amlodipine + Benazepril

...NICAR HCT and more frequently than placeboincluded nausea (3 percent vs 0 percent), hyperuricemia (4 percentvs 2 percent), dizziness (9 percent vs 2 percent), and upperrespiratory tract infection (7 percent vs 0 percent). No initial dosage adjustments are recommended with BENICAR inelderly, in moderate to ...

New Study Demonstrates that Lubiprostone May Improve Symptom Relief Rates in Adults with Irritable Bowel Syndrome with Constipation (IBS-C)

...ion (24 mcgBID), the most common adverse event was nausea (31%). Other adverseevents (greater than or equal to 5% of patients) included diarrhea(13%), headache (13%), abdominal distention (7%), abdominal pain(7%), flatulence (6%), sinusitis (5%) and vomiting (5%). For full prescribing information, visi...

Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin in Complicated Urinary Tract Infections and Acute Pyelonephritis

...related adverse events in U.S. clinicaltrials were nausea (1.5%) and diarrhea (1.2%). The safety andefficacy of LEVAQUIN in pediatric patients, adolescents (under 18),pregnant women, and nursing mothers have not been established.LEVAQUIN is contraindicated in persons with a history ofhypersensitivity to LEV...

Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load Reduction Compared to Adefovir at 48 Weeks in Study of Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients

...ain, have trouble breathing, have stomach painwith nausea and vomiting, feel cold -- especially in their arms andlegs, feel dizzy or lightheaded, or have a fast or irregularheartbeat, as they may be signs of a serious condition calledlactic acidosis (buildup of an acid in the blood). Lactic acidosis is a m...

Data Published in The Lancet Show Gardasil was 100 Percent Effective in Preventing High-Grade Vulvar and Vaginal Lesions Caused by HPV Types 16 and 18

...8.4 percent), fever (10.3percent vs. 8.6 percent), nausea (4.2 percent vs. 4.1 percent),pruritis (3.1 percent vs. 2.8 percent) and dizziness (2.8 percentvs. 2.6 percent). Dosage and administration for GARDASIL GARDASIL is a ready-to-use, three-dose, intramuscular vaccine.GARDASIL should be administered in...

Salix Pharmaceuticals Previews Digestive Disease Week 2007

... headache(8%); abdominal pain (6%); diarrhea (5%); nausea (5%); vomiting(4%); respiratory infection (4%); an...als, abdominaldistension, anal discomfort, thirst, nausea and abdominal pain weresome of the most common adverse reactions to MOVIPREPadministration. Vomiting...

Survey: Migraine Patients Taking Potentially Addictive Barbiturate or Opioid Medications Not Approved by FDA as Migraine Treatments

...alleviating the symptoms of migraines suchas pain, nausea and sensitivity to light and sound. Although barbiturates and opioids are considered effective forshort-term migraine relief, many doctors recommend againstprescribing them for long-term use because of the potential foraddiction and abuse. Phys...

BDSI Announces Positive Key Secondary Efficacy Endpoint Results for Bema Fentanyl

...her acute treatmentopportunities such as insomnia, nausea and vomiting, andinfections. The company's headquarters are located in Morrisville,North Carolina and its principal laboratory is located in Newark,New Jersey. For more information please visitwww.bdsinternational.com. Forward-Looking Statements No...

New England Journal of Medicine Publishes New Data on Gardasil, Merck's Cervical Cancer Vaccine

...8.4 percent), fever (10.3percent vs. 8.6 percent), nausea (4.2 percent vs. 4.1 percent),pruritis (3.1 percent vs. 2.8 percent) and dizziness (2.8 percentvs. 2.6 percent). Dosage and administration for GARDASIL GARDASIL is a ready-to-use, three-dose, intramuscular vaccine.GARDASIL should be administered in...

Data Suggest Cymbalta Reduced Severity of Night Pain in Patients with Diabetic Nerve Pain

...rse event cited as areason for discontinuation was nausea (4 percent), followed bysomnolence (2 percent), dizziness (2 percent), fatigue (1 percent)and vomiting (1 percent). Methods: Data were pooled from three double-blind, randomized,placebo-controlled, 12-week studies, to investigate associationsbetwee...

Trexima (Sumatriptan/Naproxen Sodium) Provided Relief of Both Traditional and Non-traditional Migraine Symptoms

...esufferers experience traditional symptoms such as nausea orsensitivity to light and sound, migraine attacks...atients experienced traditional migraine symptoms: nausea (27-33percent), sensitivity to light (69-74 percent) and sensitivity tosound (62-69 percent). Additi...

Final Vectibix Positive Pivotal Phase 3 Trial Results In Metastatic Colorectal Cancer Patients Published

...ypomagnesemia, paronychia,fatigue, abdominal pain, nausea and diarrhea. Hypomagnesemiaoccurred 6 weeks or longer after the initiation of Vectibix. Insome patients, hypomagnesemia was associated with hypocalcemia. Vectibix is indicated for the treatment of EGFr-expressing,metastatic colorectal cancer with d...

Cephalon Presents Positive Results for Fentora in Breakthrough Pain Associated with Neuropathic Conditions

...ent). The most common side effects included nausea (13 percent), dizziness (13 percent), drowsiness (10 percent), and vomiting (5 percent). Of the 102 patients included in the safety evaluation, 12 withdrew from the study due to adverse events during the titration phase; none were ...

BDSI Announces Positive Phase III Clinical Trial Results for BEMA Fentanyl

...her acute treatmentopportunities such as insomnia, nausea and vomiting, andinfections. The company's headquarters are located in Morrisville,North Carolina and its principal laboratory is located in Newark,New Jersey. For more information please visitwww.bdsinternational.com. Forward-Looking Statements No...

Idenix Announces Data Presentations at the 2007 Digestive Disease Week Meeting

...(11%), blood CPK increased (9%), cough (7%), nausea and vomiting (7%), influenza and influenza-like symptoms (7%), post-procedural pain (7%), diarrhea and loose stools (7%), and pharyngolaryngeal pain (5%). -- Grade 3-4 creatine kinase (CK) elevations occurred in 9% of TYZEKA- tre...

Millennium Discovers Biomarkers Potentially Predictive of Response to Velcade (Bortezomib) for Injection

...rted adverse eventswere asthenic conditions (64%), nausea (55%), diarrhea (52%),constipation (41%), peripheral neuropathy (39%), thrombocytopenia(36%), appetite decrease, including reports of anorexia (36%),pyrexia (34%), vomiting (33%) and anemia (29%). Twenty percent ofpatients reported at least one episo...